Prospective study on nasal polyposis: Clinical Characteristics, Treatment, Outcome and Quality of life.

Prospective study on nasal polyposis: Clinical Characteristics, Treatment, Outcome and Quality of life. - NIL

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/05/109896

Enrollment

Registered

2026-05-04

Start date

Unknown

Completion date

Unknown

Last updated

2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: Tablet prednisolone (10 mg) TDS : giving tablet prednisolone (10 mg) three times a day before surgery for one week (7 days) No comparator agent Control Intervention1: not applicable: no

Eligibility

Inclusion criteria

Inclusion criteria: Chronic rhinosinusitis patients ( of all age groups) who also have nasal polyposis are included in this study.

Exclusion criteria

Exclusion criteria: Pregnant females Immunodeficient people Patients with secondary chronic rhinosinusitis and patients who underwent revision endoscopic sinus surgery are excluded.

Design outcomes

Primary

Measure	Time frame
Reduction in SNOT 22 scoreTimepoint: 1st - Pre operatively 2nd - at 3 months after surgery (FESS)	—

Secondary

Measure	Time frame
improvement in quality of lifeTimepoint: after 3 months of surgery (FESS)	—

Countries

India

Contacts

Public ContactDr Tarjani Hindocha

GMERS Medical College - Gotri

tarjanihindocha16@gmail.com9033714530

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Jun 11, 2026